Generic Name and Formulations:
Azelastine HCl 0.05%; oph. soln; contains benzalkonium chloride.
Indications for OPTIVAR:
Treatment of ocular itching associated with allergic conjunctivitis.
Adults and Children:
<3yrs: not recommended. ≥3yrs: 1 drop in affected eye(s) twice daily.
Contact lenses (remove; may reinsert 10 minutes after administration, if eye is not red). Pregnancy (Cat.C). Nursing mothers.
Ocular burning/stinging, headache, bitter taste, asthma, conjunctivitis, dyspnea, eye pain, fatigue, flu symptoms, transient blurred vision.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
- Sexual Aids and Resources Not Readily Available at Cancer Centers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|